MAIA Biotechnology, Inc. (MAIA) stock
MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)
Close on Nov 18, 2026Market cap $79.07MP/E –Yield –
MAIA Biotechnology total assets
Total assets on the balance sheet at the end of each period.
MAIA Biotechnology's total assets was $28.24M at Jun 30, 2026. For fiscal 2025 it was $9.70M, down 4.4% from the year before. The highest annual figure on record is $12.02M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.70M | -4.4% |
| FY2024 | Dec 31, 2024 | $10.16M | +34.2% |
| FY2023 | Dec 31, 2023 | $7.57M | -37.1% |
| FY2022 | Dec 31, 2022 | $12.02M | +6.1% |
| FY2021 | Dec 31, 2021 | $11.33M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.24M | +155.7% |
| Q1 FY2026 | Mar 31, 2026 | $35.32M | +197.7% |
| Q4 FY2025 | Dec 31, 2025 | $9.70M | -4.4% |
| Q3 FY2025 | Sep 30, 2025 | $11.78M | +27.5% |
| Q2 FY2025 | Jun 30, 2025 | $11.05M | -8.1% |
| Q1 FY2025 | Mar 31, 2025 | $11.86M | +36.1% |
| Q4 FY2024 | Dec 31, 2024 | $10.16M | +34.2% |
| Q3 FY2024 | Sep 30, 2024 | $9.24M | +32.0% |
| Q2 FY2024 | Jun 30, 2024 | $12.02M | +17.1% |
| Q1 FY2024 | Mar 31, 2024 | $8.72M | -3.9% |
| Q4 FY2023 | Dec 31, 2023 | $7.57M | -37.1% |
| Q3 FY2023 | Sep 30, 2023 | $7.00M | -52.6% |
| Q2 FY2023 | Jun 30, 2023 | $10.27M | +5.2% |
| Q1 FY2023 | Mar 31, 2023 | $9.07M | -19.9% |
| Q4 FY2022 | Dec 31, 2022 | $12.02M | – |
| Q3 FY2022 | Sep 30, 2022 | $14.78M | – |
| Q2 FY2022 | Jun 30, 2022 | $9.76M | – |
| Q4 FY2021 | Dec 31, 2021 | $11.33M | – |
See a number that looks wrong?